Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q1 2023 Earnings Call Transcript

Operator: Good day and thank you for standing by. Welcome to the Sangamo First Quarter 2023 Teleconference Call. At this time, all participants are in a listen-only mode.

Related Keywords

Texas ,United States ,California ,France ,Valbonne ,Provence Alpes Côd Azur ,Brisbane ,Queensland ,Australia ,American ,America ,Mark Mcclung ,Maury Raycroft ,Alexanderd Macrae ,D Mark Mcclung ,Phillip Ramsey ,Gena Wang ,Bettinam Cockroft ,Andy Ramelmeier ,Prathyusha Duraibabu ,Sandy Macrae ,Los Angeles ,Jason Fontenot ,Louise Wilkie ,Yanan Zhu ,Ben Burnett ,Jasond Fontenot ,Bettina Cockroft ,Nathalie Dubois Stringfellow ,Gregory Harrison ,Patrick Trucchio ,Greg Harrison ,Benjamin Burnett ,Sangamo Therapeutics Inc ,Barclays ,Nasdaq ,Pfizer ,Massachusetts Institute Of Technologie Broad ,American Association Of Gene ,Novartis ,Corporate Communications ,Wells Fargo ,Sangamo Therapeutics ,Call Transcript April ,Sangamo First Quarter ,Vice President ,Investor Relations ,Chief Executive Officer ,Chief Operating Officer ,Chief Financial Officer ,Chief Scientific Officer ,Chief Development Officer ,Chief Medical ,Zinc Finger ,Executive Vice President ,Technical Operations ,American Association ,Cell Therapy Annual Meeting ,Massachusetts Institute ,Technologie Broad Institute ,Chief Operating Officer Mark ,Cohort One ,Zinc Fingers ,Biogen Novartis ,Luca Issi ,